Enliven Therapeutics, Inc.
← Back to ELVN Overview

Enliven Therapeutics, Inc. (ELVN)

Price-to-Earnings Ratio History

P/E Ratio (TTM)

-25.79

Financial Fundamentals

ELVNQuarterly Data • 5Y View

Quarterly P/E

QuarterP/E Ratio
2019-03-31-15.46
2019-06-30-12.00
2019-09-30-9.80
2019-12-31-8.93
2020-03-31-4.40
2020-06-30-11.66
2020-09-30-7.11
2020-12-31-8.38
2021-03-31-3.62
2021-06-30-2.66
2021-09-30-1.86
2021-12-31-1.03
2022-03-31-0.84
2022-06-30-0.70
2022-09-30-3.26
2022-12-310.83
2023-03-31-6.84
2023-06-30-12.45
2023-09-30-6.70
2023-12-31-7.36
2024-03-31-8.75
2024-06-30-13.84
2024-09-30-13.30
2024-12-31-12.23
2025-03-31-8.63
2025-06-30-10.23
2025-09-30-15.99
2025-12-31-8.56
2026-03-31-25.79

* P/E ratios are calculated using trailing twelve-month (TTM) earnings.